March 5, 2020 / 9:26 AM / 24 days ago

BRIEF-Cadila Healthcare Ltd gets DCGI Approval For NDA For Saroglitazar For Treatment Of NASH In India

March 5 (Reuters) - Cadila Healthcare Ltd:

* CADILA HEALTHCARE LTD - GOT APPROVAL FROM DRUG CONTROLLER GENERAL OF INDIA FOR NDA FOR SAROGLITAZAR FOR TREATMENT OF NASH IN INDIA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below